HMPL-760
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HMPL-760, covering 2025-04-09 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL [Phase 3]